DoD’s $250M Fluorspar Contract Proves Domestic Push Was Inevitable, ARES Sole Player
Don’t say we didn’t tell you so. Endeavor picked this hot tips months ago and if you have bought, you’re welcome – we love this company and are confident there’s plenty more room for growth. The Defense Logistics Agency’s $250 million, five-year acid-grade fluorspar contract (SP8000-25-R-0020), now closed for bids, has lit a fire under […]
DoD’s Fluorspar Solicitation Confirms What We Knew: Domestic Suppliers Like Ares Are Critical
We called it. The Defense Logistics Agency’s (DLA) now-closed $250 million solicitation (SP8000-25-R-0020) for acid-grade fluorspar isn’t just another procurement—it’s a neon sign that the U.S. is finally waking up to its critical minerals problem. Since its inception, Endeavour has been highlighting the risks of relying on foreign fluorspar, a linchpin for defense manufacturing from […]
Investors Eye Gold and Silver, but Palladium’s Surge is Demanding Attention
Gold and silver may be dominating headlines with record highs, but palladium is quietly staging a comeback. Prices are up more than 34% this year, driven by industrial demand and tightening supply, positioning the metal as one to watch.
Trilogy Metals Shares Surge Over 200% After U.S. Takes 10% Stake
Trilogy Metals shares skyrocketed after the U.S. government announced a $35.6 million investment, signaling a renewed federal commitment to securing America’s critical mineral supply chains and advancing domestic resource development in Alaska.
Pharma Stocks Split as Trump Unveils 100% Drug Tariff
Trump’s 100% tariff on foreign-made branded drugs has shaken markets, with analysts warning the impact won’t be evenly felt.
Should You Invest in Gold? 7 Experts Weigh In
Gold futures have surged past $3,700 an ounce, prompting experts to weigh in on whether investors should jump in—or has that ship sailed?
Nvidia to Invest $100B in OpenAI, Cementing Partnership
Nvidia and OpenAI are joining forces in a landmark $100 billion partnership, combining Nvidia’s GPU leadership with OpenAI’s AI development to shape the next era of artificial intelligence.
Next-Generation Mining Maintenance Exposes Skills Gap
Once dominated by grease and wrenches, mining maintenance is now data-driven, AI-powered, and remote—but the workforce is struggling to keep up.
Buy, Sell, or Hold: Hims & Hers Stock Surges 64%
The past six months have been a windfall for Hims & Hers Health’s shareholders as the stock surged 64%. Is now the right time to buy HIMS? Or is this rally more about investor enthusiasm than fundamentals?
This Biotech’s Phase 3 Results Could Be a Game-Changer for Investors
The next few weeks for aTyr Pharma will reveal a great deal about this company’s future. aTyr Pharma is set to transform treatment for pulmonary sarcoidosis and unlock blockbuster potential. Is the stock a good investment right now? Let’s find out.
English 
German